DGNS Relative Valuation - Diagnos Laboratorium Utama PT Tbk

Watchlist Manager

Watchlist

Price: 304 IDR Market Closed

Market Cap: Rp380B

Relative Value

The Relative Value of one DGNS stock under the Base Case scenario is hidden IDR. Compared to the current market price of 304 IDR, Diagnos Laboratorium Utama PT Tbk is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

DGNS Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	380B IDR	1.4	-199.7	-6 347.1	-6 347.1
US		CVS Health Corp NYSE:CVS	99.7B USD	0.3	212.6	14	14
US		Cigna Corp NYSE:CI	78.2B USD	0.3	12.7	0	0
US	C	Cigna Group XMUN:CGN	63.5B EUR	0.3	12.2	7.8	9.9
DE		Fresenius SE & Co KGaA XETRA:FRE	27.9B EUR	1.2	24.3	10.6	16.2
DE		Fresenius Medical Care AG XMUN:FME	23.9B EUR	1.2	33.1	10.4	22.3
US		Laboratory Corporation of America Holdings NYSE:LH	23B USD	1.7	26.9	14.4	20.2
US		Quest Diagnostics Inc NYSE:DGX	21.3B USD	2	22.4	12.2	16.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.8B EUR	0.6	16.2	6.4	13.7
US		Guardant Health Inc NASDAQ:GH	12.6B USD	14.1	-31.8	-33.6	-30.5
US		DaVita Inc NYSE:DVA	10B USD	0.7	12.9	7.3	10

				Revenue Growth	P/S to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average P/S: 2.2 1.4	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.3	5%	0.1
US		Cigna Corp NYSE:CI	0.3	8%	0
US	C	Cigna Group XMUN:CGN	0.3	8%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.2	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.7	7%	0.2
US		Quest Diagnostics Inc NYSE:DGX	2	7%	0.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	14.1	30%	0.5
US		DaVita Inc NYSE:DVA	0.7	4%	0.2

				Earnings Growth	PEG
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average P/E: 41.5 Negative Multiple: -199.7	N/A	N/A
US		CVS Health Corp NYSE:CVS	212.6	32%	6.6
US		Cigna Corp NYSE:CI	12.7	39%	0.3
US	C	Cigna Group XMUN:CGN	12.2	39%	0.3
DE		Fresenius SE & Co KGaA XETRA:FRE	24.3	71%	0.3
DE		Fresenius Medical Care AG XMUN:FME	33.1	37%	0.9
US		Laboratory Corporation of America Holdings NYSE:LH	26.9	30%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22.4	14%	1.6
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	16.2	37%	0.4
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -31.8	N/A	N/A
US		DaVita Inc NYSE:DVA	12.9	6%	2.2

				EBITDA Growth	EV/EBITDA to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average EV/EBITDA: 10.4 Negative Multiple: -6 347.1	N/A	N/A
US		CVS Health Corp NYSE:CVS	14	25%	0.6
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
US	C	Cigna Group XMUN:CGN	7.8	4%	2
DE		Fresenius SE & Co KGaA XETRA:FRE	10.6	14%	0.8
DE		Fresenius Medical Care AG XMUN:FME	10.4	10%	1
US		Laboratory Corporation of America Holdings NYSE:LH	14.4	16%	0.9
US		Quest Diagnostics Inc NYSE:DGX	12.2	8%	1.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	6.4	10%	0.6
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -33.6	N/A	N/A
US		DaVita Inc NYSE:DVA	7.3	4%	1.8

				EBIT Growth	EV/EBIT to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average EV/EBIT: 15.3 Negative Multiple: -6 347.1	N/A	N/A
US		CVS Health Corp NYSE:CVS	14	19%	0.7
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
US	C	Cigna Group XMUN:CGN	9.9	5%	2
DE		Fresenius SE & Co KGaA XETRA:FRE	16.2	20%	0.8
DE		Fresenius Medical Care AG XMUN:FME	22.3	25%	0.9
US		Laboratory Corporation of America Holdings NYSE:LH	20.2	27%	0.7
US		Quest Diagnostics Inc NYSE:DGX	16.5	11%	1.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	13.7	25%	0.5
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -30.5	N/A	N/A
US		DaVita Inc NYSE:DVA	10	4%	2.5

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Relative Value

Valuation Multiples

Multiples Across Competitors

DGNS Competitors Multiples
Diagnos Laboratorium Utama PT Tbk Competitors

See Also

Company

Help

Tools

Stocks

Diagnos Laboratorium Utama PT Tbk IDX:DGNS

Relative Value

Valuation Multiples

Multiples Across Competitors

DGNS Competitors Multiples Diagnos Laboratorium Utama PT Tbk Competitors

See Also

Company

Help

Tools

Stocks

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

DGNS Competitors Multiples
Diagnos Laboratorium Utama PT Tbk Competitors